PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 53 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $479,000 | -71.2% | 2,719,074 | -2.0% | 0.01% | -75.0% |
| Q2 2022 | $1,665,000 | -51.7% | 2,774,869 | +6.2% | 0.05% | -44.8% |
| Q1 2022 | $3,450,000 | -48.8% | 2,613,825 | +1.3% | 0.09% | -44.2% |
| Q4 2021 | $6,737,000 | +17.5% | 2,581,299 | +40.0% | 0.16% | +28.9% |
| Q3 2021 | $5,734,000 | -16.4% | 1,843,764 | 0.0% | 0.12% | -11.0% |
| Q2 2021 | $6,859,000 | +27.6% | 1,843,764 | +18.6% | 0.14% | +16.2% |
| Q1 2021 | $5,377,000 | +21.8% | 1,553,974 | +18.2% | 0.12% | +24.5% |
| Q4 2020 | $4,416,000 | -4.2% | 1,314,374 | +0.1% | 0.09% | -19.7% |
| Q3 2020 | $4,609,000 | -12.4% | 1,313,174 | +14.8% | 0.12% | -18.8% |
| Q2 2020 | $5,262,000 | +41.3% | 1,143,925 | +1.7% | 0.14% | -6.5% |
| Q1 2020 | $3,724,000 | -45.8% | 1,125,000 | 0.0% | 0.15% | -29.0% |
| Q4 2019 | $6,874,000 | +16.4% | 1,125,000 | -20.6% | 0.22% | -7.7% |
| Q3 2019 | $5,908,000 | -68.4% | 1,416,900 | -0.4% | 0.24% | -65.2% |
| Q2 2019 | $18,673,000 | +72.2% | 1,423,256 | +24.8% | 0.68% | +61.7% |
| Q1 2019 | $10,841,000 | +320.2% | 1,140,000 | +36.5% | 0.42% | +242.6% |
| Q4 2018 | $2,580,000 | – | 835,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |